A
ARYA Sciences Acquisition Corp IV
NASDAQ:ADGM
ARYA Sciences Acquisition Corp IV
NASDAQ:ADGM
Price:
1.28
USD
-9.22%
Market Closed
Market Cap:
$27.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ARYA Sciences Acquisition Corp IV
NASDAQ:ADGM
|
US |
|
P
|
Porvair PLC
LSE:PRV
|
UK |
|
A
|
ACDC Metals Ltd
ASX:ADC
|
AU |
|
Dillistone Group PLC
LSE:DSG
|
UK |
|
G
|
Great Republic Mining Corp
CNSX:GRM
|
CA |
|
B
|
Bunker Hill Mining Corp
CNSX:BNKR
|
CA |
|
Tan Chong International Ltd
HKEX:693
|
HK |
|
Suntak Technology Co Ltd
SZSE:002815
|
CN |
|
Ozak Gayrimenkul Yatirim Ortakligi AS
IST:OZKGY.E
|
TR |
|
Media and Games Invest SE
XETRA:M8G
|
MT |
|
S
|
Sejin Heavy Industries Co Ltd
KRX:075580
|
KR |
|
Barclays PLC
LSE:BARC
|
UK |
|
Platt Nera International Ltd
HKEX:1949
|
TH |
|
Uravi Defence and Technology Ltd
NSE:URAVIDEF
|
IN |
|
D
|
Douzone Bizon Co Ltd
KRX:012510
|
KR |
|
VR Resources Ltd
XTSX:VRR
|
CA |
|
Applied Graphene Materials PLC
LSE:AGM
|
UK |
|
A
|
Alkaline Water Company Inc
CNSX:WTER
|
US |
|
Kusuri No Aoki Holdings Co Ltd
TSE:3549
|
JP |
Balance Sheet
Balance Sheet Decomposition
ARYA Sciences Acquisition Corp IV
ARYA Sciences Acquisition Corp IV
Balance Sheet Decomposition is not available for
ARYA Sciences Acquisition Corp IV
ARYA Sciences Acquisition Corp IV
Balance Sheet
ARYA Sciences Acquisition Corp IV
ARYA Sciences Acquisition Corp IV
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
0
|
|
| Cash |
0
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
0
|
0
|
|
| Long-Term Investments |
0
|
150
|
152
|
41
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
150
N/A
|
152
+1%
|
41
-73%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
6
|
6
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
2
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
6
|
6
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
5
|
3
|
3
|
|
| Total Liabilities |
0
N/A
|
11
+11 100%
|
9
-21%
|
15
+68%
|
|
| Equity | |||||
| Common Stock |
0
|
150
|
152
|
40
|
|
| Retained Earnings |
0
|
10
|
9
|
15
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
139
N/A
|
143
+3%
|
26
-82%
|
|
| Total Liabilities & Equity |
0
N/A
|
150
N/A
|
152
+1%
|
41
-73%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
17
|
19
|
19
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
